PFO and Stroke: What Are the Data?

Patent foramen ovale (PFO) is a frequent finding on echocardiography and occurs in over 25% of the population. In young patients with cryptogenic stroke, the frequency is much higher suggesting paradoxical embolization may be responsible for the clinical events. There are conflicting data from studies examining the association between PFO and stroke. The combination of atrial septal aneurysm and PFO, and PFO size and severity of right-to-left shunt may add additional risk but again the data are insufficient for definite conclusions. Available information suggests no difference in subsequent stroke in patients with PFO treated with aspirin or warfarin for secondary prevention. Endovascular closure is technically feasible, but not without the possibility of periprocedural complications. Comparison of medical and endovascular closure of PFOs in patients with stroke is ongoing in 2 major randomized trials.

[1]  R. Sacco,et al.  Patent foramen ovale and the risk of ischemic stroke in a multiethnic population. , 2007, Journal of the American College of Cardiology.

[2]  W. O'Fallon,et al.  Population-based study of the relationship between patent foramen ovale and cerebrovascular ischemic events. , 2006, Mayo Clinic proceedings.

[3]  R. Sacco,et al.  Age As a Determinant of Adverse Events in Medically Treated Cryptogenic Stroke Patients With Patent Foramen Ovale , 2004, Stroke.

[4]  M. Schwerzmann,et al.  Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke. , 2004, Journal of the American College of Cardiology.

[5]  H. Reichmann,et al.  Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism. Periprocedural safety and mid-term follow-up results of three different device occluder systems. , 2004, European heart journal.

[6]  W. Burgin,et al.  Increased Pelvic Vein Thrombi in Cryptogenic Stroke: Results of the Paradoxical Emboli From Large Veins in Ischemic Stroke (PELVIS) Study , 2003, Stroke.

[7]  Paul Khairy,et al.  Transcatheter Closure versus Medical Therapy of Patent Foramen Ovale and Presumed Paradoxical Thromboemboli , 2003, Annals of Internal Medicine.

[8]  A. Grau,et al.  Prothrombin G20210A Mutation, but Not Factor V Leiden, Is a Risk Factor in Patients with Persistent Foramen ovale and Otherwise Unexplained Cerebral Ischemia , 2003, Cerebrovascular Diseases.

[9]  M. Hillbom,et al.  Factor V Leiden and prothrombin gene mutation may predispose to paradoxical embolism in subjects with patent foramen ovale , 2003, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[10]  R. Levine,et al.  Interatrial septal mobility predicts larger shunts across patent foramen ovales: an analysis with transmitral Doppler scanning. , 2003, American heart journal.

[11]  G. Anzola,et al.  Transcranial Doppler and risk of recurrence in patients with stroke and patent foramen ovale , 2003, European journal of neurology.

[12]  L. Vignolo,et al.  Inherited Thrombophilic Disorders in Young Adults With Ischemic Stroke and Patent Foramen Ovale , 2003, Stroke.

[13]  R. Sacco,et al.  Effect of Medical Treatment in Stroke Patients With Patent Foramen Ovale: Patent Foramen Ovale in Cryptogenic Stroke Study , 2002, Circulation.

[14]  J. Coste,et al.  Clinical and Imaging Findings in Cryptogenic Stroke Patients With and Without Patent Foramen Ovale: The PFO-ASA Study , 2002 .

[15]  J. Coste,et al.  Clinical and imaging findings in cryptogenic stroke patients with and without patent foramen ovale: the PFO-ASA Study. Atrial Septal Aneurysm. , 2002, Stroke.

[16]  J. Coste,et al.  Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. , 2001, The New England journal of medicine.

[17]  I. Bone,et al.  Interatrial septal abnormalities and stroke , 2000, Neurology.

[18]  H. Schuchlenz,et al.  The association between the diameter of a patent foramen ovale and the risk of embolic cerebrovascular events. , 2000, The American journal of medicine.

[19]  F. Fedele,et al.  Patent foramen ovale and its embolic implications. , 2000, The American journal of cardiology.

[20]  B Meier,et al.  Percutaneous closure of patent foramen ovale in patients with paradoxical embolism: long-term risk of recurrent thromboembolic events. , 2000, Circulation.

[21]  M. Enriquez-Sarano,et al.  Prevalence of potential risk factors for stroke assessed by transesophageal echocardiography and carotid ultrasonography: the SPARC study. Stroke Prevention: Assessment of Risk in a Community. , 1999, Mayo Clinic proceedings.

[22]  J. Bogousslavsky,et al.  Stroke recurrence in patients with patent foramen ovale , 1996, Neurology.

[23]  M. Zuber,et al.  Recurrent cerebrovascular events in patients with patent foramen ovale, atrial septal aneurysm, or both and cryptogenic stroke or transient ischemic attack. French Study Group on Patent Foramen Ovale and Atrial Septal Aneurysm. , 1995, American heart journal.

[24]  F. Chédru,et al.  Atrial Septal Aneurysm and Patent Foramen Ovale as Risk Factors for Cryptogenic Stroke in Patients Less Than 55 Years of Age: A Study Using Transesophageal Echocardiography , 1993, Stroke.

[25]  H. Leitner,et al.  The Prevalence of Deep Venous Thrombosis in Patients with Suspected Paradoxical Embolism , 1993, Annals of Internal Medicine.

[26]  R. Sacco,et al.  Patent Foramen Ovale as a Risk Factor for Cryptogenic Stroke , 1992, Annals of Internal Medicine.

[27]  W. Daniel,et al.  Diagnosis of patent foramen ovale by transesophageal echocardiography and association with cerebral and peripheral embolic events. , 1992, The American journal of cardiology.

[28]  Daniel B Hier,et al.  Infarcts of undetermined cause: The NINCDS stroke data bank , 1989, Annals of neurology.

[29]  H. J. Smith,et al.  PATENT FORAMEN OVALE IN YOUNG STROKE PATIENTS , 1988, The Lancet.

[30]  P. Lechat,et al.  Prevalence of patent foramen ovale in patients with stroke. , 1988, The New England journal of medicine.

[31]  W. Edwards,et al.  Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. , 1984, Mayo Clinic proceedings.